AI assistant
BIOGEN INC. — Director's Dealing 2015
Mar 11, 2015
30291_dirs_2015-03-11_1b3626a6-2e68-40d7-b76c-940cc3dccc24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2015-03-10
Reporting Person: PANGIA ROBERT W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-10 | Common Stock | M | 3125 | $46.99 | Acquired | 17998 | Direct |
| 2015-03-10 | Common Stock | S | 200 | $410.605 | Disposed | 17798 | Direct |
| 2015-03-10 | Common Stock | S | 300 | $411.463 | Disposed | 17498 | Direct |
| 2015-03-10 | Common Stock | S | 700 | $412.969 | Disposed | 16798 | Direct |
| 2015-03-10 | Common Stock | S | 1000 | $413.985 | Disposed | 15798 | Direct |
| 2015-03-10 | Common Stock | S | 300 | $415.143 | Disposed | 15498 | Direct |
| 2015-03-10 | Common Stock | S | 525 | $416.247 | Disposed | 14973 | Direct |
| 2015-03-10 | Common Stock | S | 100 | $417.27 | Disposed | 14873 | Direct |
| 2015-03-10 | Common Stock | M | 500 | $52.22 | Acquired | 15373 | Direct |
| 2015-03-10 | Common Stock | S | 400 | $410.055 | Disposed | 14973 | Direct |
| 2015-03-10 | Common Stock | S | 100 | $411.33 | Disposed | 14873 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-10 | Employee Stock Option (Right to Buy) | $46.99 | M | 3125 | Disposed | 2016-05-24 | Common Stock (3125) | Direct |
| 2015-03-10 | Stock Option (Right to Buy) | $52.22 | M | 500 | Disposed | 2017-05-30 | Common Stock (500) | Direct |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $410.18 (low) and $411.03 (high)
F4: This represents the weighted average price for shares sold at a range between $411.35 (low) and $411.53 (high).
F5: This represents the weighted average price for shares sold at a range between $412.47 (low) and $413.18 (high).
F6: This represents the weighted average price for shares sold at a range between $413.62 (low) and $414.28 (high).
F7: This represents the weighted average price for shares sold at a range between $414.82 (low) and $415.71 (high).
F8: This represents the weighted average price for shares sold at a range between $415.90 (low) and $416.54 (high).
F9: This represents the weighted average price for shares sold at a range between $409.67 (low) and $410.35 (high).
F10: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
F11: Options will vest in their entirety on 05/25/2007 provided that the Reporting Owner is then a member of the Issuer's Board of Directors.
F12: Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.